LCTG 001
Alternative Names: LCTG-001Latest Information Update: 28 Nov 2024
Price :
$50 *
At a glance
- Originator Lactiga
- Class Antivirals
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Common variable immunodeficiency; COVID 2019 infections; Selective immunoglobulin A deficiency
Most Recent Events
- 28 Nov 2024 No recent reports of development identified for preclinical development in Common-variable-immunodeficiency(Prevention) in USA
- 28 Nov 2024 No recent reports of development identified for preclinical development in COVID-2019-infections in USA
- 28 Nov 2024 No recent reports of development identified for preclinical development in Selective-immunoglobulin-A-deficiency(Prevention) in USA